期刊文献+

阿司匹林对肠上皮细胞的损伤作用及机制 被引量:7

Effects and mechanism of aspirin on enterocyte injury
下载PDF
导出
摘要 目的:探讨阿司匹林对肠上皮细胞增殖的影响及作用机制.方法:将不同浓度的阿司匹林溶液与肠上皮细胞株Caco-2细胞共同培养24h及48h,采用MTT法检测阿司匹林对Caco-2细胞的增殖作用.建立Caco-2单层细胞模型,采用不同浓度阿司匹林溶液处理后,用EVOM电压电阻仪测定细胞跨膜电阻抗(TER)变化.结果:在不同浓度的阿司匹林(0、0.1、1、10mmol/L)作用下,24h细胞存活率分别为96.67%±1.13%、84.32%±1.29%、62.33%±2.02%和42.99%±2.09%;48h细胞存活率分别为96.45%±1.21%、76.89±2.28%、50.28%±0.98%和32.66%±1.99%,阿司匹林对Caco-2细胞的增殖作用呈现剂量-时间依赖性(P<0.05).与对照组相比,阿司匹林作用组TER明显降低,至10mmol/L组作用72h时,TER值降低至50.1%.结论:阿司匹林可抑制肠上皮细胞的增殖,同时损伤细胞屏障功能,损伤紧密连接,且以上两种作用呈剂量和时间依赖性. AIM: To investigate the effect and mechanism of aspirin on proliferation of enterocytes. METHODS: After co-culture of aspirin solution with Caco-2 cells for 24 h and 48 h, the proliferation of Caco-2 cells in each group was examined using MTT. Caco-2 monolayer cells model was established. After treatment with different concen- trations of aspirin, Transepithelial resistance (TER) of cells was measured by EVOM voltohmmeter. RESULTS: After 24 h, the cell survival rates were 96.67% ± 1.13%, 84.32% ± 1.29%, 62.33% ± 2.02% and 42.99% ± 2.09% in groups with aspirin of 0, 0.1, 1, 10 mmol/L, respectively; after 48 h, the cell survival rates were respectively 96.45% ± 1.21%, 76.89% ± 2.28%, 50.28% ± 0.98% and 32.66% ± 1.99%. The TER in the group with aspi- rin of 10 mmol/L was reduced to 50.1% after 72 h. Multiple factors chi square test showed that the influence of aspirin on the proliferation of Caco-2 cells and the epithelial barrier was dosedependent and time-dependent. CONCLUSION: Aspirin could inhibit the prolifer-ation of enterocyte and affect the epithelial barrier, in a dose-dependent and time-dependent manner.
作者 安敏 张振玉
出处 《世界华人消化杂志》 CAS 北大核心 2009年第13期1355-1358,共4页 World Chinese Journal of Digestology
关键词 阿司匹林 紧密连接 跨膜电阻抗 CACO-2细胞 Aspirin Tight junction Transepithelialresistance Caco-2 cells
  • 相关文献

参考文献15

  • 1韩英,李世荣.非甾体类抗炎药物与食管、大肠癌的预防[J].中华消化杂志,1998,18(6):364-366. 被引量:2
  • 2Takeuchi K, Hatazawa R, Tanigami M, Tanaka A, Ohno R, Yokota A. Role of endogenous nitric oxide (NO) and NO synthases in healing of indomethacininduced intestinal ulcers in rats. Life Sci 2007; 80: 329-336.
  • 3Thiefin G, Beaugerie L. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. Joint Bone Spine 2005; 72:286-294.
  • 4Bjarnason I, Takeuchi K, Simpson R. NSAIDs: the emperor's new dogma? Gut 2003; 52:1376-1378.
  • 5Hawkey CJ. NSA-IDs, coxibs, and the intestine. J Cardiovasc Pharmacol 2006; 47 Suppl 1:S72-S75.
  • 6Somasundaram S, Sigthorsson G, Simpson RJ, Watts J, Jacob M, Tavares IA, Rafi S, Roseth A, Foster R, Price AB, Wrigglesworth JM, Bjarnason I. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID- enteropathy in the rat. Aliment Pharmacol Ther 2000; 14:639-650.
  • 7Goltsov A, Maryashkin A, Swat M, Kosinsky Y, Humphery-Smith I, Detain O, Goryanin I, Lebedeva G. Kinetic modelling of NSAID action on COX-l: focus on in vitro/in vivo aspects and drug combinations. Eur J Pharm Sci 2009; 36:122-136.
  • 8Yokomizo A, Moriwaki M. Transepithelial permeability of myricitrin and its degradation by simulated digestion in human intestinal Caco-2 cell monolayer. Biosci Biotechnol Biochem 2005; 69: 1774-1776.
  • 9Cruz N, Qi L, Alvarez X, Berg RD, Deitch EA. The Caco-2 cell monolayer system as an in vitro model for studying bacterial-enterocyte interactions and bacterial translocation. J Burn Care Rehabil 1994; 15: 207-212.
  • 10Adebayo D, Bjarnason I. Is non-steroidal anti- inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad Med J 2006; 82:186-191.

二级参考文献18

  • 1Hou W,Gastroenterology,1995年,108卷,599页
  • 2Lanza FL,Graham DY,Davis RE,Rack MF.Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury.Effect of scoring method.Dig Dis Sci,1990,35:1494~1499.
  • 3Slattery J,Warlow CP,Shorrock C J,Langman MJ.Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin-analysis of gastrointestinal bleeding during the UK-TIA trial.Gut,1995,37:509~511.
  • 4Sorensen HT,Mellemkjaer L,Blot WJ,Nielsen GL,Steffensen FH,McLaughlin JK,Olsen JH.Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.Am J Gastroenterol,2000,95:2218~2224.
  • 5Kelly JP,Kaufman DW,Jurgelon JM,Sheehan J,Koff RS,Shapiro S.Risk of aspirin-associated major uppergastrointestinal bleeding with enteric-coated or buffered product.Lancet,1996,348:1413~1416.
  • 6Zhang Y,Shaffer A,Portanova J,Seibert K,Isakson PC.Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2production.J Pharmacol Exp Ther,1997,283:1069~1075.
  • 7Spencer-Green G,Spencer-Green E.Nonsteroidal therapy of rheumatoid arthritis and osteoarthritis:how physicians manage treatment failures.J Rheumatol,1998,25:2088~2093.
  • 8Serebruany VL,Steinhubl SR,Berger PB,Malinin AI,Baggish JS,Bhatt DL,Topol EJ.Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.Am J Cardiol,2005,95:1218~1222.
  • 9Wallace JL.Nonsteroidal anti-inflammatory drugs and gastroenteropathy:the second hundred years.Gastroenterology,1997,112:1000~1016.
  • 10MacDonald TM,Morant SV,Robinson GC,Shield MJ,McGilchrist MM,Murray FE,McDevitt DG.Association of upper gastrointestinal toxicity of non-steroidal antiinflammatory drugs with continued exposure:cohort study.BMJ,1997,315:1333~1337.

共引文献16

同被引文献68

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部